TB-SPECTRUM A step forward for unraveling the immune mechanisms and tools for tuberculosis spectrum management
- Coordinator
- Institut De Investigacio En Ciencies De La Salut Germans Trias I Pujol, Spain
- Runs
- 1 January 2026 to 31 December 2029
- Status
- Running
- EU funding
- €897k
- Total cost
- —
- Partners
- 9 organisations in 8 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101236673
What the project is doing
In the project's own words, from its summary on CORDIS.
TB-SPECTRUM aims to strengthen international research collaboration among different sectors and disciplines, and to structure a network to perform high-quality, translational, and multidisciplinary research for (i) a better understanding of tuberculosis (TB) spectrum immune mechanisms; and (ii) increasing the capacities of the involved staff fostering training and networking activities, as well as increasing their inter-sectoral employability opportunities.
Understanding the host-pathogen interactions in the different phases of the spectrum is fundamental for detecting biomarkers of disease progression that can lead to new diagnostic approaches for identifying those individuals with a high-risk of developing disease if infected or for detecting subclinical TB forms. However, it is still unknown which immunological mechanisms are involved in infection/disease progression.
To unravel this knowledge gap, it is mandatory to develop collaborative research which combines different expertise in the TB field (clinics, diagnostics, treatment, clinical studies management, cellular/humoral immunology, genomics, and technology transfer, among others). For that purpose, a Consortium of nine academic and non-academic Institutions harboring TB-renowned experts has been constituted. This network is formed by specialists in the clinical management of active TB cases and their contacts (from high and low incident countries); experts in basic/applied science; and a small and medium-sized enterprise (SME) involved in the development of immune assays.
Altogether, the proposed goals will be achieved through secondments among the different sectors, which will be extremely important for progressing to a better understanding of the requirements needed in TB management and control; and will expose participants to new research environments that will reinforce multidisciplinarity. Moreover, the interaction with an SME will improve knowledge transference skills, stimulating entrepreneurship.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Institut De Investigacio En Ciencies De La Salut Germans Trias I Pujol | Badalona Barcelona | Spain | Coordinator |
| Genome Identification Diagnostics GmbH | Strassberg | Germany | Participant |
| Servicios Clinicos SA | Barcelona | Spain | Participant |
| Institutia Medico-Sanitara Publica - Institutul De Pneumologie ""chiril Draganiuc"""" | Chisinau | Moldova | Participant |
| Bingham University | Karu | NG | Associatedpartner |
| Academisch Ziekenhuis Leiden | Leiden | Netherlands | Participant |
| I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do Porto | Porto | Portugal | Participant |
| Institutul De Pneumoftiziologie Marius Nasta | Bucuresti | Romania | Participant |
| The University of Texas System | Austin | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI